Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report

Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expe...

Full description

Bibliographic Details
Main Authors: Jeremy Sugarman, Roger A. Barker, Ian Kerridge, Tamra Lysaght, Graziella Pellegrini, Douglas Sipp, Claire Tanner
Format: Article
Language:English
Published: Elsevier 2018-11-01
Series:Stem Cell Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2213671118304430
_version_ 1818032104872607744
author Jeremy Sugarman
Roger A. Barker
Ian Kerridge
Tamra Lysaght
Graziella Pellegrini
Douglas Sipp
Claire Tanner
author_facet Jeremy Sugarman
Roger A. Barker
Ian Kerridge
Tamra Lysaght
Graziella Pellegrini
Douglas Sipp
Claire Tanner
author_sort Jeremy Sugarman
collection DOAJ
description Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies. : Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies.
first_indexed 2024-12-10T06:02:04Z
format Article
id doaj.art-abf0ce7276fb40e58fd67d6679d3afa6
institution Directory Open Access Journal
issn 2213-6711
language English
last_indexed 2024-12-10T06:02:04Z
publishDate 2018-11-01
publisher Elsevier
record_format Article
series Stem Cell Reports
spelling doaj.art-abf0ce7276fb40e58fd67d6679d3afa62022-12-22T01:59:48ZengElsevierStem Cell Reports2213-67112018-11-0111510211025Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session ReportJeremy Sugarman0Roger A. Barker1Ian Kerridge2Tamra Lysaght3Graziella Pellegrini4Douglas Sipp5Claire Tanner6Berman Bioethics Institute and Department of Medicine, Johns Hopkins University, Baltimore, MD, USA; Corresponding authorJohn van Geest Centre for Brain Repair and Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UKSydney Health Ethics, University of Sydney, Sydney, NSW, AustraliaCentre for Biomedical Ethics, National University of SingaporeCentre for Regenerative Medicine, University of Modena and Reggio Emilia, Modena MO, ItalyRiken Center for Biosystems Dynamics Research and Keio University School of Medicine/Global Research Institute, Tokyo, JapanThe Centre for Stem Cell Systems (ELSI program), The University of Melbourne, Parkville, VIC, AustraliaClinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies. : Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies.http://www.sciencedirect.com/science/article/pii/S2213671118304430
spellingShingle Jeremy Sugarman
Roger A. Barker
Ian Kerridge
Tamra Lysaght
Graziella Pellegrini
Douglas Sipp
Claire Tanner
Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report
Stem Cell Reports
title Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report
title_full Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report
title_fullStr Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report
title_full_unstemmed Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report
title_short Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report
title_sort tackling ethical challenges of premature delivery of stem cell based therapies isscr 2018 annual meeting focus session report
url http://www.sciencedirect.com/science/article/pii/S2213671118304430
work_keys_str_mv AT jeremysugarman tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport
AT rogerabarker tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport
AT iankerridge tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport
AT tamralysaght tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport
AT graziellapellegrini tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport
AT douglassipp tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport
AT clairetanner tacklingethicalchallengesofprematuredeliveryofstemcellbasedtherapiesisscr2018annualmeetingfocussessionreport